Top Markets
Coin of the day
RegeneRx Biopharmaceuticals, Inc. RegeneRx Biopharmaceuticals, Inc.

RegeneRx Biopharmaceuticals, Inc.

RGRX
Classement en actions #42502
RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the... RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the advancement of therapeutic peptides, with a primary emphasis on thymosin beta 4, engineered for the protection, repair, and regeneration of tissues and organs. The company's development pipeline includes RGN-259, a preservative-free ophthalmic solution designed to restore corneal tissues following injury, disease, or other pathologies; RGN-352, an injectable formulation under investigation for its potential in treating cardiovascular ailments, central and peripheral nervous system disorders, and various other medical conditions; and RGN-137, a topical gel aimed at accelerating the healing of skin wounds and minimizing scar tissue. Strategic alliances have been forged with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. Incorporated in 1982, the company initially operated as Alpha 1 Biomedicals, Inc., adopting the name RegeneRx Biopharmaceuticals, Inc. in 2000. Its operations are headquartered in Rockville, Maryland.
Prix de l'action
$0.0007
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$1.05K
Changement (1 jour)
0.00%
Changement (1 an)
250.00%
Pays
US
Échange RegeneRx Biopharmaceuticals, Inc. (RGRX)

Catégorie

Le prix RGRX avec la capitalisation boursière de B
RegeneRx Biopharmaceuticals, Inc. RegeneRx Biopharmaceuticals, Inc.
RGRX
$0.0007
Capitalisation boursière de RegeneRx Biopharmaceuticals, Inc.(RGRX)
Capitalisation boursière: $1.05K
En August 2026, RegeneRx Biopharmaceuticals, Inc. a une capitalisation boursière de $1.05K. Cela fait de RegeneRx Biopharmaceuticals, Inc. la 42502nd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de RegeneRx Biopharmaceuticals, Inc. du 2003 au 2026
RGRX par rapport au top 5 des plus populaires stocks
Prix pour RGRX L’actif B La capitalisation boursière de B Résultats
RegeneRx Biopharmaceuticals, Inc. RegeneRx Biopharmaceuticals, Inc.
$3,595,757 $1.05K
$5.383T +513,679,631,777.65%
RegeneRx Biopharmaceuticals, Inc. RegeneRx Biopharmaceuticals, Inc.
$2,954,557 $1.05K
$4.423T +422,079,554,882.38%
RegeneRx Biopharmaceuticals, Inc. RegeneRx Biopharmaceuticals, Inc.
$2,778,874 $1.05K
$4.160T +396,982,040,069.30%
RegeneRx Biopharmaceuticals, Inc. RegeneRx Biopharmaceuticals, Inc.
$2,446,876 $1.05K
$3.663T +349,553,715,007.09%
RegeneRx Biopharmaceuticals, Inc. RegeneRx Biopharmaceuticals, Inc.
$1,931,165 $1.05K
$2.891T +275,880,768,095.10%